Platelet-Derived Growth Factor Promotes Periodontal Regeneration in Localized Osseous Defects: 36-Month Extension Results From a Randomized, Controlled, Double-Masked Clinical Trial

BACKGROUND: Recombinant human platelet-derived growth factor (rhPDGF) is safe and effective for the treatment of periodontal defects in short-term studies up to 6 months in duration. We now provide results from a 36-month extension study of a multicenter, randomized, controlled clinical trial evalua...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Periodontol
Autors principals: Nevins, Myron, Kao, Richard T., McGuire, Michael K., McClain, Pamela K., Hinrichs, James E., McAllister, Bradley S., Reddy, Michael S., Nevins, Marc L., Genco, Robert J., Lynch, Samuel E., Giannobile, William V.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5715458/
https://ncbi.nlm.nih.gov/pubmed/22612364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1902/jop.2012.120141
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars